创伤后体外膜氧合的应用
该研究回顾了2006年1月至2015年11月单中心一级成人创伤资源中心46例创伤后使用ECMO的患者,排除7例静脉-动脉ECMO后分析39例VV-ECMO患者,出院生存率44%。生存者体重指数和插管时PaCO2较低,死亡者损伤更重(中位损伤严重度评分41 vs 25,p=0.03)、到院动脉pH更低、住院时间更短(11 vs 41天,p=0.006)。94%生存者接受肝素抗凝 vs 55%死亡者(p=0.01)。作者认为创伤后急性肺损伤可考虑VV-ECMO,能耐受全身抗凝与生存改善相关。
要点
- 创伤后VV-ECMO患者出院生存率44%(39例中),静脉-动脉ECMO者被排除。
- 死亡者损伤更重:中位损伤严重度评分41 vs 25(p=0.03),到院动脉pH更低,住院时间更短(11 vs 41天,p=0.006)。
- 生存者插管时体重指数和PaCO2较低。
- 94%生存者接受肝素抗凝 vs 55%死亡者(p=0.01),能耐受全身抗凝与生存改善相关。
- 41%发生至少一种ECMO相关并发症,但与死亡率无关;损伤机制和ECMO指征与死亡率无关。
适用人群与场景
- 2006年1月至2015年11月单中心一级成人创伤资源中心收治的创伤后急性呼吸衰竭接受ECMO的患者。
- 排除需要静脉-动脉ECMO的患者(n=7)。
研究设计与关键结果
- 单中心回顾性研究,46例创伤后ECMO患者,排除7例静脉-动脉ECMO后分析39例(85%)静脉-静脉ECMO患者,出院生存率44%。
- 中位年龄28岁;生存者插管时体重指数和PaCO2较低。
- 死亡者中位损伤严重度评分41 vs 生存者25(p=0.03),到院动脉pH更低,住院时间更短(11 vs 41天,p=0.006)。
- 损伤机制和ECMO指征与死亡率无关;41%发生至少一种ECMO相关并发症,与死亡率无关。
- 94%生存者接受肝素抗凝 vs 55%死亡者(p=0.01);抗凝的生存者与死亡者中位损伤严重度评分和创伤性脑损伤存在率无显著差异。
证据类型、等级与局限
- 治疗性研究,证据等级V级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,创伤后急性肺损伤使用静脉-静脉ECMO应考虑用于特殊患者人群。
- 作者认为,能耐受全身抗凝与生存改善相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The use of extracorporeal membrane oxygenation (ECMO) for acute respiratory failure after injury is controversial and poorly described.
METHODS: We reviewed our single-center experience with use of ECMO from January 2006 to November 2015 at a Level 1 primary adult resource center for trauma to determine the association of in-hospital mortality with patient demographics and clinical variables.
RESULTS: Forty-six patients were treated with ECMO. Patients requiring venoarterial ECMO (n = 7) were excluded. Thirty-nine (85%) were cannulated for venovenous ECMO. Of these, 44% patients survived to discharge. Median age was 28 years. Survivors had a lower BMI and PaCO2 at time of cannulation. Nonsurvivors were more severely injured (median Injury Severity Score, 41 vs. 25; p = 0.03), had a lower arterial pH on arrival, and a shorter length of stay (11 vs. 41 days; p = 0.006). Neither mechanism of injury nor indication for ECMO was associated with mortality. Forty-one percent developed at least one ECMO-related complication, but this was not associated with mortality. Ninety-four percent of the survivors were anticoagulated with heparin versus 55% of nonsurvivors (p = 0.01). Median Injury Severity Score and presence of TBI were not significantly different between survivors and nonsurvivors who were anticoagulated.
CONCLUSION: The use of venovenous ECMO for acute lung injury after trauma should be considered in special patient populations. Ability to tolerate systemic anticoagulation was associated with improved survival.
LEVEL OF EVIDENCE: Therapeutic study, level V.
参考来源
- Ahmad SB, Menaker J, Kufera J, et al. Extracorporeal membrane oxygenation after traumatic injury. J Trauma Acute Care Surg. 2017. PMID: 28225528. doi:10.1097/TA.0000000000001352
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。